Published June 2021 | Version v1
Journal article

Enlightening the Immune Mechanism of the Abscopal Effect in a Murine HCC Model and Overcoming the Late Resistance With Anti-PD-L1

  • 1. Department of Microbiology, College of Medicine, Inje University, Busan (Korea, Republic of)
  • 2. Department of Surgery, Busan Paik Hospital, College of Medicine, Inje University, Busan (Korea, Republic of)
  • 3. Department of Internal Medicine, Busan Paik Hospital, College of Medicine, Inje University, Busan (Korea, Republic of)
  • 4. Department of Internal Medicine, Haeundae Paik Hospital, College of Medicine, Inje University, Busan (Korea, Republic of)
  • 5. Department of Radiation Oncology, Busan Paik Hospital, College of Medicine, Inje University, Busan (Korea, Republic of)
  • 6. Department of Pathology, Busan Paik Hospital, College of Medicine, Inje University, Busan (Korea, Republic of)

Description

The establishment of a preclinical model of the abscopal effect on hepatocellular carcinoma (HCC) and evaluation of whether the hypofractionated radiation therapy (RT) multitumor Hepa1-6 mouse HCC model could be used to suppress nonradiated tumor mass was performed in this study.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.ijrobp.2020.12.031

Additional details

Identifiers

DOI
10.1016/j.ijrobp.2020.12.031;
PII
S0360301620347246;

Publishing Information

Journal Title
International Journal of Radiation Oncology, Biology and Physics
Journal Volume
110
Journal Issue
2
Journal Page Range
p. 510-520
ISSN
0360-3016
CODEN
IOBPD3

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
53124497
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
EVALUATION; HEPATOMAS; MICE; RADIOSENSITIVITY; RADIOTHERAPY
Descriptors DEC
ANIMALS; CARCINOMAS; DISEASES; MAMMALS; MEDICINE; NEOPLASMS; NUCLEAR MEDICINE; RADIOLOGY; RODENTS; SENSITIVITY; THERAPY; VERTEBRATES

Optional Information

Copyright
Copyright (c) 2020 Elsevier Inc. All rights reserved.